Nebil S. is a seasoned professional in the biopharmaceutical field with extensive experience in operations and manufacturing related to gene therapy and biologics. Currently serving as Director of Cell Therapy Supplier Development at AstraZeneca since March 2025, Nebil oversees risk and performance management for strategic suppliers supporting Cell Therapy programs. Prior to this role, Nebil held several key positions at Charles River Laboratories, including Sr. Director of Operations where oversight was provided for Manufacturing Sciences & Technology and GMP Manufacturing. Additional roles include Sr. Manager of Gene Therapy Manufacturing Operations at Catalent Pharma Solutions, Manager at ABL Inc., and Supervisor at AstraZeneca, showcasing a consistent focus on operational excellence in biologics and gene therapy manufacturing.
This person is not in any teams
This person is not in any offices